Cost-Effectiveness of Levetiracetam for Patients With Juvenile Myoclonic Epilepsy: A Modeling Approach By The Brazilian Public Health Care System Perspective
2017 ◽
Vol 20
(9)
◽
pp. A722-A723
M Kayo
◽
RP Rosim
◽
A Duva
◽
AF Ballalai Ferraz
◽
E Carmo
2017 ◽
Vol 20
(9)
◽
pp. A924
2010 ◽
Vol 13
(7)
◽
pp. A549
2011 ◽
Vol 14
(7)
◽
pp. A563
◽
J. Ramírez-Gámez
◽
H. Dueñas-Tentori
2013 ◽
Vol 16
(3)
◽
pp. A92-A93
R.K. Fujii
◽
P. Hájek
◽
G.D.A Lanzara
◽
D.F. Manfrin
◽
J. Mould
2013 ◽
Vol 16
(3)
◽
pp. A89
◽
R.K. Fujii
◽
D.F. Manfrin
◽
Lanzara G.D.A.
◽
P. Hájek
◽
J. Mould
2011 ◽
Vol 14
(7)
◽
pp. A275-A276
◽
C. Pepe
◽
V. Teich
◽
J.F. Mould
2012 ◽
Vol 15
(4)
◽
pp. A105
◽
R.K. Fujii
◽
J.F. Mould
◽
R.A. Fernandes
◽
F. Furlan
◽
D.F. Manfrin
2012 ◽
Vol 15
(4)
◽
pp. A143-A144
◽
J.F. Mould
◽
R.K. Fujii
◽
E. Lazaridis
◽
D.F. Manfrin
2009 ◽
Vol 12
(7)
◽
pp. A502-A503
RA Fernandes
◽
FF Quintella
◽
VD Teich
2014 ◽
Vol 17
(3)
◽
pp. A113
N.B. Santoni
◽
T.G. Melo
◽
E.P. Almeida
Close
Export Citation Format
Close
Share Document
Close